Saadia Rashid
<p>Dr. Rashid is American Academy of Ophthalmology board-certified ophthalmologist, specializing in the field of vitreo-retinal diseases. She is an expert in the repair of complex retinal detachments (including diabetic and sickle cell tractional retinal detachments), macular holes, giant retinal tears, epiretinal membranes, and dislocated lens. Her medical areas of expertise includes management of macular degeneration, diabetic retinopathy, sickle cell retinopathy and retinopathy of prematurity in premature babies. </p><p>She completed her Ophthalmology Residency at the prestigious Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston. She then completed two years surgical retina fellowship at the University of California, Davis.</p><p><span style="font-size:11.0pt;font-family:'Calibri',sans-serif;">Dr. Rashid is the lead ophthalmologist for the New York City Football Club since January 2022.</span></p><p> </p><p> </p>
<p>Dr. Rashid completed her Post-Doctoral Research Fellowship at the Schepens Eyes Research Institute, Harvard Medical School where she was involved in the study of inflammatory cytokines in ocular inflammatory diseases. Her current research interests are novel techniques in repair of macular holes.</p>
Jelena M. Pavlovic
<p>Jelena Pavlovic, MD, PhD is an Assistant Professor of Neurology at the Albert Einstein College of Medicine. Dr. Pavlovic earned her B.S. from Ramapo College of New Jersey where she double majored in Biology and Chemistry while on full academic scholarship. She completed her MD and PhD in Molecular Medicine at Pennsylvania State University College of Medicine. She was an intern in internal medicine at St. Vincent’s Hospital in New York City and a neurology resident at the Albert Einstein College of Medicine/Montefiore Medical Center, where she was also a Chief Resident. She subsequently continued her training as a fellow in Headache Medicine and Facial Pain at the Montefiore Headache Center.</p>
<p>Dr. Pavlovic is board certified by the American Board of Psychiatry and Neurology. She is a member of the American Academy of Neurology (AAN), the American Headache Society (AHS), and the International Headache Society (IHS). In addition to prior awards, she received the AHS’s "Frontiers in Headache Research" scholarship in 2012.</p>
<p>Dr. Pavlovic’s research interests broadly focus on migraine biophenotypes with a particular interest in processes that lead to the progression from episodic to chronic migraine. </p>
Raminder K. Parihar
Dr. Parihar is focused on expanding the DBS to improve the quality of life of patients with tremors, Parkinson's disease, and dystonia.
Dr. Parihar is interested in studying gait disorders and working to find advanced therapies to improve them.
<p><span id="docs-internal-guid-7b0a3849-df15-2ae7-5b01-dfa6f02928ba">1. Parihar, R; Mahoney, JR; Verghese, J. Relationship of Gait and Cognition in the Elderly. Curr Transl Geriatr Exp Gerontol Rep. 2013 Sep 1;2(3)</span></p>
<p>2. Bakshi K, Parihar R, Goswami SK, Walsh M, Friedman E, Wang HY. Prenatal cocaine exposure uncouples mGluR1 from Homer1 and Gq proteins. PLoS One. 2014 Mar 13;9(3):e91671. doi: 10.1371/journal.pone.0091671. eCollection 2014</p>
<p>3. <span id="docs-internal-guid-7b0a3849-df16-5152-5f73-3dd4cf8c18ee">Parihar R, Alterman R, Papavassiliou E, Tarsy D, Shih LC. Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action Tremor. Tremor Other Hyperkinetic Mov. 2015 July 6;5: 321</span></p>
<p>4. <span id="docs-internal-guid-7b0a3849-df16-989c-b0c2-e768f5de3e9a">Tarsy, Daniel, and Raminder K. Parihar. Medication-Induced Movement Disorders. Cambridge, 2015. Print.</span></p>
<p>Raminder Parihar, MD, is Director, Neuromodulation at Montefiore Einstein and Assistant Professor, Neurology at our Albert Einstein College of Medicine. Dr. Parihar evaluates and treats patients with different movement disorders. She is also largely involved in evaluating patients for candidacy for deep brain stimulation (DBS) surgery for the treatment of different movement disorders and initiating and following up stimulation programming.</p><p>After obtaining her Bachelor of Science in biomedical sciences from the City College of New York in 2007, Dr. Parihar completed her Doctor of Medicine at Stony Brook University School of Medicine in 2009. She then came to Albert Einstein College of Medicine, where she completed an internship in medicine in 2010 and her residency in adult neurology in 2013, where she was Chief Resident in her final year. Dr. Parihar completed a fellowship in movement disorders at Harvard/Beth Israel Deaconess Medical Center in 2014.</p><p>Dr. Parihar’s research focuses on gait disorders and how they can predict cognitive impairment in patients with Parkinson's disease. She also studies the impact of deep brain stimulation in improving the quality of life in patients with movement disorders. Her work has been published in peer-reviewed book chapters and publications, and she has shared her work through lectures and platform and abstract presentations.</p><p>Dr. Parihar is a Diplomate of the American Board of Psychiatry and Neurology. She is a member of the American Academy of Neurology, the Movement Disorders Society and the American Medical Association (AMA). In 2023, Dr. Parihar was a recipient of the Marquis Who's Who in America Award.</p>
John J. McGinley
<p>Dr. John McGinley is Assistant Professor in Neurology at the Albert Einstein College of Medicine and the Director of Neuropsychology at the Montefiore Comprehensive Epilepsy Center. He is a Licensed Psychologist/Clinical Neuropsychologist in the Montefiore Department of Neurology. Dr. McGinley completed his clinical psychology internship in adult and pediatrics at St. Charles Hospital and Rehabilitation Center on Long Island and earned his Ph.D. in Clinical Health Psychology at the Ferkauf Graduate School of Psychology, Yeshiva University where he annually guest lecturer's on the topics of Epilepsy.</p>
<p> </p>
<p> </p>
<p style="text-align: center;"><strong>RECENT PUBLICATIONS</strong></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt; color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Mandge V, Correa DJ, <strong>McGinley J</strong>, Boro A, Legatt AD, Haut SR. Factors associated with patients not proceeding with proposed resective epilepsy surgery. <em>Seizure</em>, 91:402-408. (2021)</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt; color: #201f1e; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Dobrowolski C, <strong>McGinley J</strong>, Fazzari M, Su J, Bingham KS, Anderson N, Ruttan L, Beaton DE, Wither JE, Tartaglia MC, Kakvan M, Bonilla D, Choi MY, Fritzler MJ, Diaz-Martinez JP, Katz P, Green R, Putterman C, Touma Z. (First Published online 9/22/2022). </span><span style="font-size: 11pt; color: #2a2a2a; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Association of mycophenolate and azathioprine use with cognitive function in systemic lupus. <em>Rheumatology, 62</em>(5): 1860-1869 (2023)</span></p>
<p>John McGinley, PhD, FAES, is Director, Neuropsychology, Comprehensive Epilepsy Management Center at Montefiore Einstein and Assistant Professor, Neurology at our Albert Einstein College of Medicine. Dr. McGinley's clinical focus includes the presurgical neuropsychological assessment of adults and children with epilepsy, the multidisciplinary administration of the Wada procedure and the facilitation of intraoperative language mapping. He also performs presurgical neuropsychological evaluations of patients with Parkinson's disease and other movement disorders, such as dystonia and essential tremor to assist with the determination of deep brain stimulation (DBS) suitability. Dr. McGinley also conducts brief neuropsychological evaluations for the assessment of dementia at the Center for the Aging Brain (CAB) as part of a multidisciplinary team of Neurologists, Geriatricians and Neuropsychologists.</p><p>After he obtained his Bachelor of Arts in psychology from Saint Peter's College in 1989, Dr. McGinley earned his Master of Science in applied psychology with a research concentration from the Stevens Institute of Technology in 1992. He earned his Master of Social Work at the City University of New York in 1996 and combined his clinical and research interests through the attainment of a scientist-practitioner Doctor of Philosophy in clinical health psychology at Yeshiva University. in 2001. Dr. McGinley completed his psychology internship at St. Charles Hospital & Rehabilitation Center in 2001, with postdoctoral training in pediatric neuropsychology at private practices in Long Island and New Jersey in 2007.</p><p>Dr. McGinley’s research focuses on epilepsy surgery outcomes, the impact of deep brain stimulation, the identification of biomarkers for mild cognitive impairment (MCI), shared cognitive pathways in epilepsy and autism and the impact of medications on neurological diseases such as systemic lupus. Dr. McGinley is a co-investigator for the Montefiore Einstein research project, “Effects of Deep Brain Stimulation (DBS) on Cognitive and Emotional Behaviors,” and is a collaborator on another project titled “Vocal Biomarker Discovery for Mild Cognitive Impairment Detection.” He is also the developer of a modified Wada procedure for “standard-of-care” presurgical epilepsy assessment in persons with early-onset visual impairment/blindness (VI/B). His work has been shared through numerous peer-reviewed publications and invited presentations.</p><p>Dr. McGinley is a Licensed Psychologist and a Fellow of the American Epilepsy Society (FAES) and currently serves as a member of the AES Annual Conference’s Pediatric Content Committee. He is also a member of the National Academy of Neuropsychology (NAN) and the American Academy of Neurology (AAN). In 2016, Dr. McGinley was selected to attend the inaugural “International Training Course on Neuropsychology in Epilepsy” at Château de Rosay, France, sponsored by the International League Against Epilepsy (ILAE).</p>
Jincy Mathew
Rishi Malhotra
<span style="caret-color:#000000;font-family:Calibri, Arial, Helvetica, sans-serif;font-size:16px;text-size-adjust:auto;background-color:#ffffff;">Subarachnoid hemorrhage, Intracerebral Hemorrhage, Ischemic Stroke, Status Epilepticus, Neuromuscular Respiratory Failure, CNS Infections</span>
<span style="caret-color:#000000;font-family:Calibri, Arial, Helvetica, sans-serif;font-size:16px;text-size-adjust:auto;background-color:#ffffff;">Intracerebral Hemorrhage</span>
<p>Rishi Malhotra, MD, is Director of Neurocritical Care, Director of the Neuroscience ICU and Director of the Neurocritical Care Fellowship, as well as Associate Professor of Neurology, Medicine and Neurological Surgery at Montefiore Einstein. Dr. Malhotra’s clinical focus includes the critical care management of subarachnoid hemorrhage, intracerebral hemorrhage, traumatic brain injury, acute spinal cord injury, ischemic stroke, status epilepticus, brain tumors, neuromuscular respiratory failure and central nervous system infections.</p><p>A graduate of the combined BA/MD program at Brooklyn College, Dr. Malhotra completed his Doctor of Medicine with State University of New York - Downstate Medical Center in 2004. After completing his internal medicine internship at St. Luke’s-Roosevelt Hospital in 2005, Dr. Malhotra completed his three-year neurology residency at Columbia University Medical Center in 2008. He then pursued a neurocritical care fellowship at Columbia University Medical Center and Weill Cornell Medical Center, which he completed in 2010.</p><p>Dr. Malhotra’s scholarly interests include intracerebral hemorrhage, hypoxic-ischemic brain injury and status epilepticus. He has shared his work through peer-reviewed journals, books, abstracts and poster presentations.</p><p>Dr. Malhotra is board certified in Neurology and Neurocritical Care. He is a member of the Neurocritical Care Society.</p>
David M. Kaufman
<p><span style="font-family: Arial;">David Myland Kaufman, Professor of Neurology and Psychiatry and Behavioral Sciences, was graduated from the medical school of the University of Chicago and completed training in internal medicine and then neurology at Montefiore Medical Center / Albert Einstein College of Medicine (AECOM) hospitals. During his residency, Dr. Kaufman originated the nation-wide course, which he still directs, Clinical Neurology for Psychiatrists. More than 25,500 psychiatry residents and attendings have attended the course, which has served as the basis for his classic textbook, <em>Clinical Neurology for Psychiatrists</em>, (Elsevier) currently in its eighth edition and available in Italian, Japanese, and Spanish translations. He is also a co-editor of <em>Child and Adolescent Neurology for Psychiatrists</em> (Lippincott).</span></p>
<p><span style="font-family: Arial;">Dr. Kaufman has also been a visiting professor at Ben Gurion University, Yale University, Pritzger / University of Chicago, and other American medical schools, and U.S. Naval Medical Centers, as well as a frequent lecturer at AECOM. He is a member of medical school's Leo M. Davidoff Society for excellence in teaching. </span></p>
<p><span style="font-family: Arial;">In addition to his educational role at AECOM hospitals, Dr. Kaufman in partnership with Dr. Michael Swerdlow founded the quintessential neurology faculty practice K&S at Montefiore Hospital. K&S is the largest and longest surviving faculty practice in the institution. Drs. Kaufman and Swerdlow also give neurology consultation and attending rounds and supervise neurology clinics at Montefiore. In the clinics and faculty practice, Dr. Kaufman concentrates on the neurologic aspects of psychiatric illness and movement disorders. He works closely with the psychiatrists and, for botulinum treatment of certain dystonias, the neuromuscular group. Dr. Kaufman is the 2007 recipient of Montefiore's Staff and Alumni award for outstanding service.</span></p>
In addition to his educational role at AECOM and its hospitals, Dr. Kaufman in partnership with Dr. Michael Swerdlow founded the quintessential neurology faculty practice K&S at Montefiore Hospital. K&S is the largest and longest-surviving faculty practice in the institution. Drs. Kaufman and Swerdlow also give neurology consultations and attend rounds and supervise neurology clinics at Montefiore. In the clinics and faculty practice, Dr. Kaufman concentrates on the neurologic aspects of psychiatric illness and movement disorders. He works closely with psychiatrists and, for botulinum treatment of certain dystonia, the neuromuscular group.
From his research interests, Dr. Kaufman has published clinical studies of central nervous system infections, heroin overdose-induced pulmonary edema, Covid’s effect on Parkinson's disease patients, and other topics. He concentrates on teaching medical students in their neuroscience courses, psychiatry and neurology residents, and psychiatrists preparing for their Board examinations.
<p>Kaufman DM, Geyer HL, Milstein MM: "Kaufman's Clinical Neurology for Psychiatrists," Elsevier, 8th Edition, 2017</p>
<p>Kaufman DM, Smuckler DJ: Neurologic Disease (in) Blumenfeld M, Strain JJ, "Psychosomatics," Lippincott Williams & Wilkins, 2006</p>
<p>David Kaufman, MD, an attending physician and Professor of Neurology and of Psychiatry and Behavioral Sciences at Montefiore Einstein, concentrates on the neurologic aspects of psychiatric illness and movement disorders. He provides neurology consultations for in-patients and out-patients, serves as the attending on consultation and ward rounds, and supervises neurology clinics at Montefiore Einstein. He works closely with psychiatrists and, for botulinum treatment of certain dystopias, the neuromuscular group.</p><p>After earning his Bachelor of Arts from the University of Rochester in 1964, Dr. Kaufman earned his Doctor of Medicine degree from the University of Chicago School of Medicine in 1968. He pursued his postdoctoral training at Montefiore, completing his internal medicine internship and residency in 1971. In 1975, he completed the four-year neurology residency at Albert Einstein College of Medicine hospitals. He has been a steadfast member of Montefiore and Einstein communities ever since.</p><p>From his research interests, Dr. Kaufman has published clinical studies of central nervous system infections, heroin overdose-induced pulmonary edema, COVID’s effect on Parkinson disease patients, and other topics. He has been a member of editorial boards for Internal Medicine Bulletin and Medical Meetings: Pearls & Perspectives, and a consultant and reviewer for numerous medical journals. He teaches medical students in their neuroscience course, psychiatry and neurology residents, and psychiatrists preparing for their Board examinations. He has been a Visiting Professor at Ben Gurion University, Yale University, Pritzker/University of Chicago, and other American medical schools, and at U.S. Naval Medical Centers, as well as a frequent lecturer at the Albert Einstein College of Medicine.</p><p>Dr. Kaufman innovated the long-standing, annual, national course, Clinical Neurology and Psychiatry for Psychiatrists, developed a noteworthy neuropsychiatry seminar and authored the book, <em>Kaufman’s Clinical Neurology for Psychiatrists</em>, now in its 9th edition.</p><p>Dr. Kaufman is board certified in Internal Medicine, and Psychiatry and Neurology. He is a fellow of the American Academy of Neurology and the American College of Physicians. He is also a member of the American Neuropsychiatric Association and the Movement Disorder Society. A devoted educator, Dr. Kaufman has received many accolades for his excellence in medical teaching, including induction into the Leo M. Davidoff Society in 1993, the American Academy of Neurology award in 2001 and the Montefiore Staff and Alumni Award in 2007.</p>
Tannaz Iranpour Boroujeni
Howard Geyer
<p>Dr. Howard Geyer is Director, Division of Movement Disorders, Montefiore, and Assistant Professor, Neurology, Albert Einstein College of Medicine. He received his MD and PhD degrees from the University of Pennsylvania. He was chief resident in Neurology at Montefiore, where he also completed a fellowship in Clinical Neurophysiology. He completed an additional fellowship in Movement Disorders at Beth Israel Medical Center. Dr. Geyer regularly lectures and contributes to book chapters and journal articles on a variety of neurologic topics.</p>